ALNYLAM PHARMACEUTICALS, INC.
Nasdaq · CIK 0001178670 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$2.5B
Cost Of Revenue
$505.8M
Operating Income
$500.1M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.5B | - | - |
| Cost Of Revenue | $505.8M | - | - |
| Operating Income | $500.1M | - | - |
| Net Income | $370.5M | - | - |
| Eps Basic | 2.78 | - | - |
| Eps Diluted | 2.71 | - | - |
| Cash And Equivalents | $1.7B | - | - |
| Total Assets | $5.6B | - | - |
| Total Liabilities | $4.2B | - | - |
| Shareholders Equity | $1.4B | - | - |
| Operating Cash Flow | $397.2M | - | - |
| Capital Expenditures | $56.5M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | ALNYLAM PHARMACEUTICALS, INC. | 2026-07-30 | 0001178670-26-000062 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-06-03 | 0001178670-26-000048 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000038 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000037 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000042 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000036 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000041 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000035 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000040 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000034 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-22 | 0001178670-26-000039 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-05-14 | 0001178670-26-000017 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-04-07 | 0001178670-26-000014 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-06 | 0001735276-26-000063 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-06 | 0001735276-26-000062 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-06 | 0001735276-26-000061 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-06 | 0001735276-26-000060 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-06 | 0001735276-26-000059 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000053 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000052 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000051 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000050 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000049 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-04 | 0001735276-26-000048 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-02 | 0001735276-26-000041 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-02 | 0001735276-26-000040 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-02 | 0001735276-26-000039 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-03-02 | 0001735276-26-000038 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-25 | 0001735276-26-000032 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-17 | 0001735276-26-000028 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-17 | 0001735276-26-000027 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-17 | 0001735276-26-000026 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-17 | 0001735276-26-000025 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-17 | 0001735276-26-000029 |
| 10-K | ALNYLAM PHARMACEUTICALS, INC. | 2026-02-12 | 0001628280-26-007497 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-01-14 | 0001735276-26-000014 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-01-14 | 0001735276-26-000013 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-01-14 | 0001735276-26-000012 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-01-14 | 0001735276-26-000011 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2026-01-14 | 0001735276-26-000015 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-12-01 | 0001735276-25-000125 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-11-19 | 0001735276-25-000123 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-11-14 | 0001735276-25-000120 |
| 10-Q | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-30 | 0001628280-25-047345 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000114 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000113 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000118 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000117 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000116 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-10-03 | 0001735276-25-000115 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-09-11 | 0001735276-25-000097 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-09-02 | 0001735276-25-000094 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000090 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000089 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000088 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000087 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000092 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-19 | 0001735276-25-000091 |
| 4 | ALNYLAM PHARMACEUTICALS, INC. | 2025-08-15 | 0001735276-25-000079 |
| 10-Q | ALNYLAM PHARMACEUTICALS, INC. | 2025-07-31 | 0001178670-25-000090 |